It mitigates cardiac inflammation, fibrosis, and apoptosis by modulating the SIRT1/p53 signaling pathway and inhibiting the NLRP3 inflammasome, thereby ameliorating MI/R-induced cardiac dysfunction (170). This evidence concerns the gene SIRT1 and myocardial infarction.